tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ALNY Stock Latest News

Alnylam Pharma Appoints New Chief R&D Officer
Company AnnouncementsAlnylam Pharma Appoints New Chief R&D Officer
4d ago
8K
ALNY
Alnylam names Pushkal Garg as EVP, chief research and development officer
PremiumThe Fly
Alnylam names Pushkal Garg as EVP, chief research and development officer
5d ago
ALNY
Alnylam price target raised to $338 from $330 at JPMorgan
PremiumThe Fly
Alnylam price target raised to $338 from $330 at JPMorgan
11d ago
ALNY
Cautious Outlook on Alnylam Pharma: Hold Rating Amid Incremental EU Approval and Promising US Sales Projections
PremiumRatings
Cautious Outlook on Alnylam Pharma: Hold Rating Amid Incremental EU Approval and Promising US Sales Projections
13d ago
ALNY
Alnylam receives European Commission approval of AMVUTTRA
PremiumThe Fly
Alnylam receives European Commission approval of AMVUTTRA
14d ago
ALNY
Alnylam Pharma’s Strong Execution and Innovation in ATTR-CM Space Drives Positive Outlook
PremiumRatingsAlnylam Pharma’s Strong Execution and Innovation in ATTR-CM Space Drives Positive Outlook
21d ago
ALNY
Promising Market Outlook and Strong Product Pipeline Drive Buy Rating for Alnylam Pharma
Premium
Ratings
Promising Market Outlook and Strong Product Pipeline Drive Buy Rating for Alnylam Pharma
27d ago
ALNY
Positive Buy Rating for Alnylam Pharma Driven by Promising Clinical Data and Strategic Advancements
Premium
Ratings
Positive Buy Rating for Alnylam Pharma Driven by Promising Clinical Data and Strategic Advancements
1M ago
ALNY
Alnylam presents contemporary analysis of HELIOS-B Phase 3 study of vutrisiran
PremiumThe Fly
Alnylam presents contemporary analysis of HELIOS-B Phase 3 study of vutrisiran
1M ago
ALNY
Alnylam Pharma Re-elects Directors at Annual Meeting
PremiumCompany Announcements
Alnylam Pharma Re-elects Directors at Annual Meeting
1M ago
8K
ALNY
Alnylam to present data on HELIOS-B Phase 3 study of vutrisiran
PremiumThe Fly
Alnylam to present data on HELIOS-B Phase 3 study of vutrisiran
1M ago
ALNY
Alnylam Pharma’s Strong Market Position and Amvuttra’s Impressive Sales Growth Drive Buy Recommendation
PremiumRatings
Alnylam Pharma’s Strong Market Position and Amvuttra’s Impressive Sales Growth Drive Buy Recommendation
2M ago
ALNY
Alnylam Pharma’s Strong Commercial Momentum and Promising Pipeline Justify Buy Rating and $500 Price Target
PremiumRatingsAlnylam Pharma’s Strong Commercial Momentum and Promising Pipeline Justify Buy Rating and $500 Price Target
2M ago
ALNY
Cautious Outlook on Alnylam Pharma Amid Mixed Financial Results and Market Uncertainties
Premium
Ratings
Cautious Outlook on Alnylam Pharma Amid Mixed Financial Results and Market Uncertainties
2M ago
ALNY
Alnylam price target raised to $349 from $331 at UBS
Premium
The Fly
Alnylam price target raised to $349 from $331 at UBS
2M ago
ALNY
Alnylam Pharma: Strong Market Position and Promising Growth with Buy Rating from Maury Raycroft
PremiumRatings
Alnylam Pharma: Strong Market Position and Promising Growth with Buy Rating from Maury Raycroft
2M ago
ALNY
Alnylam Pharma’s Strong Q1 Performance and Strategic Initiatives Drive Buy Rating with $336 Price Target
PremiumRatings
Alnylam Pharma’s Strong Q1 Performance and Strategic Initiatives Drive Buy Rating with $336 Price Target
2M ago
ALNY
Alnylam Pharmaceuticals Reports Strong Q1 2025 Growth
PremiumCompany Announcements
Alnylam Pharmaceuticals Reports Strong Q1 2025 Growth
2M ago
ALNY
Alnylam Pharmaceuticals Reports Strong Start to 2025
PremiumCompany Announcements
Alnylam Pharmaceuticals Reports Strong Start to 2025
2M ago
ALNY
Alnylam Pharma: Strong Strategic Positioning and Growth Prospects Justify Buy Rating
PremiumRatingsAlnylam Pharma: Strong Strategic Positioning and Growth Prospects Justify Buy Rating
2M ago
ALNY
Alnylam Pharma: Hold Rating Amid Steady Growth and Market Uncertainties
Premium
Ratings
Alnylam Pharma: Hold Rating Amid Steady Growth and Market Uncertainties
2M ago
ALNY
Alnylam Pharma’s Growth Potential: Buy Rating Backed by Strong Sales and Future Projections
Premium
Ratings
Alnylam Pharma’s Growth Potential: Buy Rating Backed by Strong Sales and Future Projections
2M ago
ALNY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >